24 October 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

2025

Browse announcements from the Press Release India archive.

UPDATED THROUGHOUT THE DAY
Business wire490

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

ZIIHERA plus TEVIMBRA and chemotherapy demonstrated clinically meaningful and statistically significant improvements in PFS and OS versus trastuzumab and chemotherapy ZIIHERA plus chemotherapy showed a clinically meaningful and statistically significant improv